Placement of retrievable self-expandable metallic stents with barbs into patients with obstructive prostate cancer

European Radiology

Volumn 23, Issue 3, 2013, Pages 780-785

  Song, Ho Young ^a   Kim, Choung Soo ^a   Jeong, In Gab ^a   Yoo, Dalsan ^a   Kim, Jin Hyoung ^a   Nam, Deok Ho ^b   Bae, Jae Ik ^c   Park, Jung Hoon ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

^c Ajou University School of Medicine   (South Korea)

Author keywords

Barb; Prostate cancer; Retrievable self expandable metallic stents; Transurethral resection of the prostate; Urinary retention

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DEVICE REMOVAL; DISEASE SEVERITY; FEASIBILITY STUDY; FOLLOW UP; HEART INFARCTION; HEMATURIA; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; MALE; METAL STENT; METASTASIS; MULTIMODALITY CANCER THERAPY; NITINOL STENT; POSTVOID RESIDUAL URINE VOLUME; PRIORITY JOURNAL; PROSTATE CANCER; RETRIEVABLE SELF EXPANDABLE METALLIC STENT WITH BARB; SELF EXPANDING STENT; STONE FORMATION; STRESS INCONTINENCE; TRANSURETHRAL RESECTION; URINE FLOW RATE;

EID: 84878606876     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-012-2650-8     Document Type: Article

References (25)

1. Crain DS, Amling CL, Kane CJ (2004) Palliative transurethral prostate resection for bladder outlet obstruction in patients with locally advanced prostate cancer. J Urol 171:668-671
2. Mazur AW, Thompson IM (1991) Efficacy and morbidity of "channel" TURP. Urology 38:526-528
3. McGowan DG (1980) The adverse influence of prior transurethral resection on prognosis in carcinoma of the prostate treated by radiation therapy. Int J Radiat Oncol Biol Phys 6:1121-1126
4. Hanks GE, Leibel S, Kramer S (1983) The dissemination of cancer by transurethral resection of locally advanced prostate cancer. J Urol 129:309-311
5. Forman JD, Order SE, Zinreich ES et al (1986) The correlation of pretreatment transurethral resection of prostatic cancer with tumour dissemination and disease-free survival. A univariate and multivariate analysis. Cancer 58:1770-1778
6. Krupski TL, Stukenborg GJ, Moon K, Theodorescu D (2010) The relationship of palliative transurethral resection of the prostate with disease progression in patients with prostate cancer. BJU Int 106:1477-1483
7. Song HY, Do YS, Han YM et al (1994) Covered, expandable esophageal metallic stent tubes: experiences in 119 patients. Radiology 193:689-695
8. Kim JH, Song HY, Shin JH et al (2007) Metallic stent placement in the palliative treatment of malignant gastroduodenal obstructions: prospective evaluation of results and factors influencing outcome in 213 patients. Gastrointest Endosc 66:256-264
9. Ornellas LC, Stefanidis G, Chuttani R, Gelrud A, Kelleher TB, Pleskow DK (2009) Covered Wallstents for palliation of malignant biliary obstruction: primary stent placement versus reintervention. Gastrointest Endosc 70:676-683
10. Kim CS, Song HY, Jeong IG et al (2011) Temporary placement of covered retrievable expandable nitinol stents with barbs in high-risk surgical patients with benign prostatic hyperplasia: work in progress. J Vasc Interv Radiol 22:1420-1426
11. Barry MJ, Fowler FJ Jr, O'Leary MP et al (1992) The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 148:1549-1557
12. Antonarakis ES, Eisenberger MA (2011) Expanding treatment options for metastatic prostate cancer. N Engl J Med 364:2055-2058
13. Oefelein MG (2004) Prognostic significance of obstructive uropathy in advanced prostate cancer. Urology 63:1117-1121
14. Chapple CR, Milroy EJG, Rickards D (1990) Permanently implanted urethral stent for prostatic obstruction in the unfit patient. Preliminary report. Br J Urol 66:58-65
15. McLouglin J, Jager R, Abel PD, Williams G (1990) The use of prostatic stents in patients with urinary retention who are unfit for surgery. An interim report. Br J Urol 66:66-70
16. Williams G, Coulange C, Milroy EJG, Sarramon JP, Rubben H (1993) The Urolume, a permanently implanted prostatic stent for patients at high risk for surgery. Results from 5 collaborative centres. Br J Urol 72:335-340
17. Milroy E, Chapple CR (1993) The Urolume stent in the management of benign prostatic hyperplasia. J Urol 150:1630-1635
18. Oesterling JE, Kaplan SA, Epstein HB, Defalco AJ, Reddy PK, Chancellor MB (1994) The North American experience with the UroLume endoprosthesis as a treatment for benign prostatic hyperplasia: long-term results. The North American UroLume Study Group. Urology 44:353-362
19. Masood S, Djaladat H, Kouriefs C, Keen M, Palmer JH (2004) The 12-year outcome analysis of an endourethral wallstent for treating benign prostatic hyperplasia. BJU Int 94:1271-1274
20. Shah DK, Kapoor R, Badlani GH (2003) Experience with urethral stent explantation. J Urol 169:1398-1400
21. Armitage JN, Cathcart PJ, Rashidian A, De Nigris E, Emberton M, van der Meulen JH (2007) Epithelializing stent for benign prostatic hyperplasia: a systematic review of the literature. J Urol 177:1619-1624
22. Song HY, Cho KS, Sung KB, Han YM, Kim YG, Kim CS (1995) Self-expandable metallic stents in high-risk patients with benign prostatic hyperplasia: long-term follow-up. Radiology 195:655-660
23. van Dijk MM, Mochtar CA, Wijkstra H, Laguna MP, de la Rosette JJ (2006) The bellshaped nitinol prostatic stent in the treatment of lower urinary tract symptoms: experience in 108 patients. Eur Urol 49:353-359
24. Yoon CJ, Song HY, Kim JH et al (2010) Temporary placement of a covered, retrievable, barbed stent for the treatment of hormone-induced benign prostatic hyperplasia: technical feasibility and histologic changes in canine prostates. J Vasc Interv Radiol 21:1429-1435
25. Crisostomo V, Song HY, Maynar M, Sun F, Soria F, Lima JR, Yoon CJ (2007) Evaluation of the effects of temporary covered nitinol stent placement in the prostatic urethra: short-term study in the canine model. Cardiovasc Intervent Radiol 30:731-737